XML 23 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2022
Jan. 31, 2022
Current assets:    
Cash and cash equivalents $ 540,583 $ 315,235
Restricted cash 400 400
Accounts receivable, net of allowance of $7,522 as of April 30, 2022 and $5,584 as of January 31, 2022 79,855 75,939
Inventories 45,305 35,879
Prepaid expenses and other current assets 46,086 36,603
Total current assets 712,229 464,056
Property and equipment, net 35,196 34,593
Intangible assets, net 99,719 107,209
Operating lease right-of-use assets 23,970 25,535
Goodwill 209,927 218,484
Other assets 6,275 6,020
Total assets 1,087,316 855,897
Current liabilities:    
Accounts payable 35,350 27,576
Accrued and other current liabilities 95,596 84,328
Deferred revenue 81,881 77,142
Total current liabilities 212,827 189,046
Deferred revenue, noncurrent 75,610 69,666
Debt, noncurrent 294,070 0
Operating lease liabilities 24,034 25,370
Deferred tax liabilities 14,597 17,697
Other long-term liabilities 1,086 7,104
Total liabilities 622,224 308,883
Commitments and contingencies (Note 8)
Stockholders’ equity (deficit):    
#REF! 34 33
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of April 30, 2022 and January 31, 2022; 0 issued and outstanding as of April 30, 2022 and January 31, 2022 0 0
Additional paid-in capital 1,387,139 1,366,855
Accumulated other comprehensive income (loss) (21,160) (8,219)
Accumulated deficit (900,921) (811,655)
Total stockholders’ equity 465,092 547,014
Total liabilities and stockholders’ equity $ 1,087,316 $ 855,897
Common stock, shares authorized (in shares) 1,000,000,000 1,000,000,000
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000